Overview

Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder

Status:
Completed
Trial end date:
2020-02-25
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess efficacy and safety of ACT-541468 in subjects with insomnia disorder. Efficacy will be evaluated on sleep onset and sleep maintenance.
Phase:
Phase 3
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.